Morgan Stanley’s Top European Pharmaceutical Picks for Investors

view original post

Bayer’s menopause drug, Lynkuet, received a recommendation for approval from the European Medicines Agency (EMA), moving it closer to market access in the EU. The company is also set to receive a €180 …